CRISPR Therapeutics to Present at Investor Conferences in May – Nasdaq
Chaffey Breeze |
CRISPR Therapeutics to Present at Investor Conferences in May
Nasdaq BASEL, Switzerland and CAMBRIDGE, Mass., May 12, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology into transformative medicines, today … CRISPR: The Future of Medicine and Human Evolution China racing ahead to beat cancer with CRISPR gene editing Crispr Therapeutics AG (CRSP) Releases Quarterly Earnings Results, Beats Expectations By $0.06 EPS |
